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Objective. The aim of this study was to investigate the extent of placental lesions associated with blood pressure (BP) levels in
pregnancies complicated by hypertension. Methods. 55 singleton pregnancies complicated by mild hypertension were recruited
and compared to 55 pregnancies complicated by severe hypertension. The histological assessment was carried out with regard to
the following aspects: vessels number/ﬁeld of vision, infarction, villous ﬁbrinoid necrosis, villous hypermaturity, avascular villi,
calciﬁcations, lymphohistiocytic villitis, and thickened vessels. Statistical analysis was performed by SPSS. Results. All placental
lesions were observed more often in the severe hypertension group. Vessels number was signiﬁcantly decreased, and infarction
and villous ﬁbrinoid necrosis were signiﬁcantly increased in the placentas of the severe hypertension group compared to the mild
hypertension group (P<0.001). Conclusion. This study supports that the extent of placental lesions in hypertensive pregnancies is
correlated with hypertension level and so highlights blood pressure level as a mirror of placental function.
1.Introduction
The term gestational hypertension is used now to describe
any form of new-onset pregnancy-related hypertension.
There are ﬁve types of hypertensive disorders: (1) Gesta-
tional hypertension. (2) Preeclampsia. (3) Eclampsia. (4)
preeclampsia superimposed on chronic hypertension. (5)
chronic hypertension [1].
Hypertensivedisorderscomplicatingpregnancyarecom-
mon and form one of the deadly triad, along with hem-
morage and infection, that contribute greatly to maternal
and fetal morbidity and mortality. Many studies esti-
mate that hypertension is responsible for 2.6% to 7.6%
of maternal deaths [2–5]. Pregnancies complicated with
preeclampsia have a high incidence of preterm delivery [6],
fetal growth restriction, low birth weight, placental abrup-
tion, caesarian delivery, liver insuﬃciency, subcapsular liver
hematoma, cerebral edema, renal failure, thrombocytopenia,
and intravascular coagulation.
The complications of hypertensive disorders in preg-
nancy have been attributed to abnormalities in the placenta
[7, 8]. Therefore the placenta of the hypertensive woman has
gained much interest, and several pathological changes have
been described [9]. Placental villous angiogenesis may soon
be viewed as central to normal perinatal development and
survival [10].
The aim of this study was to test this hypothesis by
investigating various macroscopic and microscopic morpho-
logicalfeaturesoftheplacentainpregnanciescomplicatedby
severe hypertension compared to pregnancies complicated
by mild hypertension.
2.MaterialsandMethods
2.1. Study Design and Participants. In this prospective study
the population at recruitment consisted of 323 pregnant
women with hypertensive disorders as admission possible2 Obstetrics and Gynecology International
diagnosis. Inclusion criteria were singleton pregnancy, ges-
tational hypertension, preeclampsia, eclampsia, preeclamp-
sia superimposed on chronic hypertension, and chronic
hypertension. These women were hospitalized in the high-
risk pregnancy unit of “Alexandra” Maternity University
Hospital, First department of Obstetrics and Gynaecology,
in Athens. The protocol was approved by the hospital ethics
committee, and informed consent was obtained from all
pregnant women.
2.2. Clinic Blood Pressure Measurements. Clinic BP measure-
ments were obtained by a mercury sphygmomanometer in
all subjects three consecutive times. The ﬁrst measurement
was taken at the beginning of the visit, 5 minutes after
sitting down; the second was taken 2 minutes later, and
the third immediately before application of the ambulatory
BP-monitoring equipment. The mean of the three systolic
values and the mean of the three diastolic values of the same
patient were the clinic systolic blood pressure (SBP) and
the clinic diastolic blood pressure (DBP), respectively. Study
participants remained seated with the arm comfortably
placed at heart level, whereas measurements were obtained
for each one by the same doctor, who was blinded to the
study hypothesis.
Deﬁnitions of mild and severe hypertension are the fol-
lowing:
(i) Mild hypertension was deﬁned as BP elevation of
≥140/90mmHg on 2 measurements 4 hours apart
during 24h by sphygmomanometer [11–13].




2.3. ABPM Measurements and Assessment. All subjects un-
derwent ABPM for 24 hours with a Spacelabs 90207 am-
bulatory blood pressure monitor. The cuﬀ was ﬁxed to
the nondominant arm with tape. Automatic blood pressure
readings were taken at 15-minute intervals, and at least
three valid BP measurements per hour over 24 hours were
needed for the purpose of the study. Study participants
were hospitalized during ABPM, but they were instructed
to have usual activities (walking, sleeping, eating,...). The
accuracy of ABPM devices was checked monthly by means
of 10 automatic and 10 oscillatory BP readings taken
simultaneouslyfromthesamearmviaY-tube.Inallinstances
the values did not diﬀer by >5mmHg. The assessment of
ABPM was performed at the hypertensive center of the
Department of Clinical Therapeutics (Alexandra Hospital,
Athens University, Greece).
2.4. Other Parameters Registration. In the women consisting
the study group, age, gestational age, parity, weight gain,
birthweight, gestational age at delivery, placenta weight,
neonatal sex, and proteinuria were recorded. Proteinuria was
deﬁned as excretion of ≥300mgr or 2gr of protein in a 24-
hoururinecollection,apartwithnoevidenceofurinarytract
infection. Gestational age was assessed by the last menstrual
period or by a ﬁrst trimester ultrasound scan if there was a
discrepancy of more than a week.
2.5. Pathologic Examination of Placenta Bed. A pathologist,
blinded to all clinical data except of gestational age (in order
to assess the villous maturation), reviewed all histological
samples. The placentas were rinsed in water and left to drain
of blood for at least 2 hours. In all cases the placenta was
sliced into 2cm thick coronal sections. The samples were
controlled macroscopically for umbilical vessels abnormali-
ties and calciﬁcations. Representative specimens were taken
from the cord insertion, full thickness of macroscopically
normal placenta, peripheral part of placenta, placental
membranes, and from abnormal areas. The placentas were
weighed without umbilical cord. All samples were ﬁxed
in 10% formal-saline solution. After 24 hours embedded
in paraﬃn, histological sections were taken by microtome
(4µm). All samples were stained with hematoxylin and
eosin. The biopsy specimens were examined by routine light
microscopy (original magniﬁcation x40). We calculated the
ratio (Fetal/Placental weight ratio) between placental weight
and infant birth weight. The histological assessment was
carried out with regard to the following aspects: villous
hypermaturity, ischemia, lymphohistiocytic villitis, presence
of avascular villi, massive perivillous ﬁbrin deposition,
villous ﬁbrinoid necrosis, number of vessels per ﬁeld of
vision, vessel wall thickening and calciﬁcations.
Deﬁnitions of main placental lesions are the following:
(i) Ischemia was deﬁned as moderate when increased
maturation and Tenney-Parker changes were present
and severe when micro- or macroscopical infarcts
were observed.
(ii) Vessels’ number/ﬁeld of vision, as the number of
vessels was calculated by a pathologist.
(iii) Infarction, assessed at gross and microscopical exam-
ination.
(iv) Villous ﬁbrinoid necrosis, a condition where villous
stroma is replaced with ﬁbrinoid.
(v) Villous hypermaturity was deﬁned when there was
a numerous small terminal villi before the 40th
week and numerous small cross-sections of highly
capillarized terminal villi.
(vi) Calciﬁcations, assessed at gross examination.
(vii) Lymphohistiocytic villitis was diagnosed by the pres-
ence of numerous lymphocytes and macrophages in
the villous stroma.
(viii) Avascular villi were diagnosed when a group of at
least 5 ﬁbrotic avascular villi without inﬂammation
and without mineralization were seen.
(ix) Thickened vessels were diagnosed by the presence of
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2.6.StatisticalAnalysis. Subjectswereanonymisedatrecruit-
ment, and data were entered on a database distribution table
concerning categorical variables. Mean value, standard devi-
ation, standard error, and 95% conﬁdence interval described
the continuous variables.
Correlation assessment between blood pressure groups
and categorical variables of population was based on inde-
pendence test X2 (with continuity correction as necessary)
or Fisher’s test. Linear Pearson’s r correlation coeﬃcient
was used for the evaluation between continuous variables
of sample in two blood pressure groups. One-way variance
analysis(ANOVA)combinedwithunequalvariationscorrec-
tion or t-test was used for continuous variables distribution
evaluation between blood pressure groups.
All tests were 2 sided, and level of statistical signiﬁcance
was set at 5%.
3. Results
Of 323 women, in whom blood pressure was found ab-
normal (SBP ≥ 140mmHg or/and DBP ≥ 90mmHg), by
routine oﬃce (sphygmomanometer) measurements, 42 did
not record abnormal hypertensive values by ABPM. Then,
42 were excluded because they are suspected for episodic
or white coat hypertension, or autonomic dysfunction.
Investigation was therefore limited to 281 women. Of 281
women, 186 (66.2%) recorded mild hypertension, and 95
(33.8%) recorded severe hypertension.
In the severe hypertension group A SBPmean (by
ABPM) was 147.47 ± 7.40 (132.42–163mmHg) and DBP-
mean 93.90 ± 6.53 (84.13–109.75mmHg) whereas in the
mild hypertension group B SBPmean was 132.45 ± 5.75
(126.88–139.38mmHg) and DBPmean 83.08 ± 4.18 (80.50–
89mmHg) during 24h.
Histological sections were taken from 55 placentas of
the mild hypertension group B and from 55 placentas of
the severe hypertension group A. Furthermore, statistical
analysis took place on two groups.
The main characteristics of the population are pre-
sented in Table 1 (maternal, fetal, and placental data). No
diﬀerences existed between the groups regarding maternal
age. Maternal weight gain was oddly lower in group A
(P = 0.025), probably because of nutrition management.
Nulliparous women were signiﬁcantly more in pregnancies
complicated by severe hypertension than mild hypertension
(group A = 76.36% versus group B = 60%, P = 0.013).
Gestational age at recruitment diﬀered signiﬁcantly
between two groups (group A = 30.65 ± 4.40 weeks; group
B = 32.38 ± 5.23 weeks; P = 0.006), possibly because of
earlier onset of severe hypertension. Proteinuria greater than
300mgr/24h was presented in signiﬁcantly more women of
group A than group B (80% versus 65.45%, P<0.001).
Proteinuria greater than 2gr was observed in signiﬁcantly
more women of group A than group B (38.18% versus
12.72%, P<0.001). Preterm deliveries were signiﬁcantly
more in pregnancies complicated by severe hypertension
(group A = 67.27%, group B = 38.18%, P<0.001). The
male/female ratio was signiﬁcantly higher in group A (group
A = 1.41, group B = 1.02, P<0.001).
Fetal weights resulted signiﬁcantly lower in the severe
hypertension group A (P<0.001). However, since ges-
tational age at delivery was higher in mild hypertension
pregnancies (35.66 ± 2.88 weeks) than severe hypertension
pregnancies (34.04 ± 3.12), fetal weight remained signiﬁ-
cantly lower in severe hypertension group A after correcting
for gestational age (1875.36 ± 675.19 versus 2057.79 ±
631.36, P<0.01). Signiﬁcantly lower placental weights
(P<0.001) were found in pregnancies complicated by
severe hypertension and remained signiﬁcantly lower after
correction for gestational age (group A = 354.62 ± 122.33gr,
group B = 427 ± 137. 67gr, P<0.01). Fetal/placental weight
ratios were signiﬁcantly lower in group A.
The results of the histomorphological examination of
placentas of women with severe hypertension (group A)
compared with mild hypertension (group B) are shown in
Table 2.
There were no cases of umbilical vessel abnormalities
(numerical or morphological) and pathological ﬁndings
from teguments between both groups. The number of
vessels/ﬁeld of vision was signiﬁcantly decreased in group
A( g r o u pA= 35.63 ± 8.47; group B = 43.6 ± 7.91; P<
0.001). The presence of infarction and villous ﬁbrinoid
necrosis was apparent, mainly in the severe hypertension
group (P<0.001). Villous hypermaturity was signiﬁcantly
more often in group A than group B (40% versus 25.45%,
P = 0.051).Althoughavascularvilli,calciﬁcations,thickened
vessels and lymphohistiocytic villitis were noted more often
in the severe hypertension group than mild hypertension
group, the results were not signiﬁcantly diﬀerent.
4. Discussion
Obstetrical and fetal or neonatal complications are common
in pregnancies complicated with hypertensive disorders. It
is believed that in these pregnancies impaired placental
function, in terms of abnormal placental weight or histol-
ogy, may account for this phenomenon. We assessed the
relative placental weight and deﬁned several histological
abnormalities in placentas of mild and severe hypertension
groups. Histological abnormalities such as the presence
of villous ﬁbrinoid necrosis, villous hypermaturity, and
placental infarction were observed signiﬁcantly more often
in the hypertensive placentas, which is in agreement with
other studies [9, 14, 15]. Placental dysfunction may aﬀect
oxygen exchange and lead to a state of oxidative stress and
chronic-fetal hypoxemia [7]. Placental infarctions are the
most common placental lesions, and their presence is a
continuum from normal changes to extensive and patho-
logical involvement. If they are numerous, thick, centrally
located, and randomly distributed, placental insuﬃciency
may develop [16]. Avascular villi, villitis are more frequent
in preeclampsia [17]. Necrosis of villous tissue develops
from ischemia. Histopathological features include ﬁbrinoid
degeneration of the trophoblast, calciﬁcation, and ischemic
infractions.
The goal of this study was to correlate the extent of
placental lesions with the level of hypertensive disorders.4 Obstetrics and Gynecology International
Table 1: Maternal, fetal and placental data.
Group A (Severe hypertension) Group B (Mild hypertension)
Maternal age (years) 32.01 ±4.54 32.42 ±5.46
Gestational age at recruitment (weeks) 30.65 ±4.40∗∗ 32.85 ±5.23
Weight gained (kgr) 11.88 ± 5.58∗∗∗∗∗ 13.47 ±6.61
Nulliparous 76.36%∗∗∗∗ 60%
Proteinuria > 300mgr/24h 80%∗ 65.45%
Proteinuria > 2gr/24h 38.18%∗ 12.72%
Gestational age at delivery (weeks) 34.04 ±3.12∗ 35.66 ±2.88
Fetal birth weight (gr) 1875.36 ±675.19∗∗∗ 2057.79 ±631.36
Placental weight (gr) 354.62 ±122.33∗∗∗ 427 ±137.67
Fetal/Placental weight ratios 5.53 ±0.99∗∗∗∗∗∗ 5.98 ±0.94
Preterm deliveries 67.27%∗ 38.18%
Male/female ratio 1.41 1.02
Mean ± s.d. ∗P<0.001, ∗∗P = 0.006, ∗∗∗P<0.01, ∗∗∗∗P = 0.013, ∗∗∗∗∗P = 0.053, ∗∗∗∗∗∗P = 0.025.
Table 2: Findings of histomorphological examination of placentas in severe hypertension group A versus mild hypertension group B.
Group A Placentas (Severe hypertension) Group B Placentas (Mild hypertension)
Vessels number/ﬁeld of vision (mean ± s.d) 35.63 ±8.47∗ 43.6 ±7.91
Infarction 72.72%∗ 40%
Villous ﬁbrinoid necrosis 72.72%∗ 32.72%
Villous hypermaturity 40%∗∗ 25.45%
Avascular villi 10.9% 7.27%
Calciﬁcations 32.72% 25.45%
Lymphohistiocytic villitis 1.81% 0%
Thickened vessels 25.45% 23.63%
∗P<0.001, ∗∗P = 0.051.
The conclusion was that signiﬁcantly extensive placental
lesions were associated with higher level of hypertension.
In the current study we found that the number of ves-
sels/ﬁeld of vision (magniﬁcation x40, standard micrometer)
was signiﬁcantly less in pregnancies complicated with severe
hypertension than mild hypertension. This is consistent with
other studies [12, 18, 19] although they have been referred
in IUGR cases. Vascularization of the placental villi starts at
day 21 after conception. From 26 weeks of gestation until
term the villous vascular growth undergoes a change from
branching to nonbranching angiogenesis. These specialized
structures are the main site of diﬀusional gas and nutrition
exchange between the maternal and fetal circulations. Con-
sequently, fetoplacental blood ﬂow is severely impaired and
transplacentalgasandnutritionexchangeispoor,placingthe
fetus at risk of hypoxia, acidosis, and low birth weight.
In general, placental and fetal size and weight roughly
correlate in a linear fashion. There is also evidence that
fetal growth dependents on placental weight, which is less
with small-for-gestational age infants [20]. When the rate
of uteroplacental ﬂow is chronically reduced, there is a
tight direct linear correlation between the rate of mean
uteroplacental blood ﬂow and placental weight. The placenta
has the ability to control the growth of the fetus. The
mean birthweight and gestational age at delivery are lower,
and preterm deliveries are higher in hypertension [21].
Birthweight is inﬂuenced from proteinuria. The presence
of increased proteinuria predicted an adverse pregnancy
outcome [22]. In this study gestational age at delivery, birth-
weight and placental weight after correcting for gestational
age are less in the severe hypertension group than in the
mild hypertension group, and so it conﬁrms the hypothesis
that the level of hypertension is correlated with the level of
birthweight, placental weight, and gestational age at delivery.
Our ﬁndings about birthweight, gestational age at delivery
are consistent with other studies [4, 11].
ABPM is a useful diagnostic and therapeutic tool in
hypertensive patients [23]. Automated BP measurement is
more likely to identify patients conventionally characterized
as hypertensive who have been misdiagnosed. The assess-
ment of hypertensive pregnancies using ABPM appears to
improve the ability to identify correctly patients who are at
risk for poor obstetric outcome [24]. In the current study,
42 pregnant women, with abnormal oﬃce blood pressure
measurements, did not record any blood pressure elevation
greater than 140/90mmHg by ABPM. These women are
suspected for episodic hypertension, autonomic dysfunction
[25] or white-coat phenomenon [26]. Although there are
studies about women dissatisfaction, compliance problems,
and sleep disturbance from ABPM devices [27, 28], thereObstetrics and Gynecology International 5
was not dissatisfaction nor compliance problems from the
pregnant women after explaining to them in detail the
beneﬁts of ABPM.
5. Conclusion
Our ﬁndings support the hypothesis that impaired placental
function accounts for hypertensive disorders in pregnancy.
Moreover, we conclude that placental lesions in hypertensive
pregnancies, such as infarctions, villous ﬁbrinoid necrosis,
and villous hypermaturity, are signiﬁcantly correlated with
hypertension severity. Furthermore, the placenta vascular-
ization and angiogenesis are signiﬁcantly poorer when the
hypertension level is higher.
Neonatal and placenta weight are signiﬁcantly lower in
pregnanciescomplicatedwithseverehypertensioncompared
with mild hypertension. Proteinuria and preterm deliveries
are signiﬁcantly more often in severe than mild hypertensive
pregnancies.
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